Yu Chen
10PUBLICATIONS
47CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (10)
Sort by Publication Date:
|Dec 11, 2025
Anti-LAG-3 Antibody LBL-007 plus Tislelizumab and Chemotherapy as First-Line Therapy for Advanced Nasopharyngeal Carcinoma: A Multicenter Phase 2 Trial.Dongchen Sun, Gang Chen, Yu Chen
|Oct 08, 2025
Efficacy and Safety of BL-B01D1 in Patients With Locally Advanced or Metastatic Urothelial Carcinoma: A Phase II Clinical Trial.Xiaojie Bian, Tiejun Yang, Huaqi Yin
|May 03, 2025
Differences of clinical features, prognosis and genetic mutations in Chinese patients with malignant melanoma and additional primary tumours.Jing Lin, Zhongqiao Lin, Yanping Chen
|Jan 06, 2025
Atezolizumab plus bevacizumab in patients with unresectable or metastatic mucosal melanoma: 3-year survival update and multi-omics analysis.Jie Dai, Tianxiao Xu, Lifeng Li
|Aug 25, 2023
Phase Ib study of anlotinib in combination with anti-PD-L1 antibody (TQB2450) in patients with advanced acral melanoma.Yu Du, Jie Dai, Lili Mao
|Jan 27, 2023
An Immunogenic Cell Death-Related Gene Signature Reflects Immune Landscape and Predicts Prognosis in Melanoma Independently of BRAF V600E Status.Lizhu Chen, Yaoming Wen, Jiani Xiong
Pageof 2
